was read the article
array:25 [ "pii" => "S2174204914001706" "issn" => "21742049" "doi" => "10.1016/j.repce.2014.02.011" "estado" => "S300" "fechaPublicacion" => "2014-09-01" "aid" => "480" "copyright" => "Sociedade Portuguesa de Cardiologia" "copyrightAnyo" => "2014" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "ssu" "cita" => "Rev Port Cardiol. 2014;33:555-60" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4954 "formatos" => array:3 [ "EPUB" => 187 "HTML" => 3896 "PDF" => 871 ] ] "Traduccion" => array:1 [ "pt" => array:20 [ "pii" => "S0870255114001474" "issn" => "08702551" "doi" => "10.1016/j.repc.2014.02.014" "estado" => "S300" "fechaPublicacion" => "2014-09-01" "aid" => "480" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "ssu" "cita" => "Rev Port Cardiol. 2014;33:555-60" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5391 "formatos" => array:3 [ "EPUB" => 166 "HTML" => 4162 "PDF" => 1063 ] ] "pt" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Artigo de revisão</span>" "titulo" => "Prevalência da anticoagulação oral em doentes com fibrilhação auricular em Portugal: revisão sistemática e meta‐análise de estudos observacionais" "tienePdf" => "pt" "tieneTextoCompleto" => "pt" "tieneResumen" => array:2 [ 0 => "pt" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "555" "paginaFinal" => "560" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "The prevalence of oral anticoagulation in patients with atrial fibrillation in Portugal: Systematic review and meta‐analysis of observational studies" ] ] "contieneResumen" => array:2 [ "pt" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "pt" => true ] "contienePdf" => array:1 [ "pt" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig1" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1645 "Ancho" => 2250 "Tamanyo" => 202040 ] ] "descripcion" => array:1 [ "pt" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Prevalência da anticoagulação oral em doentes com FA. ACO: anticoagulação oral.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Daniel Caldeira, Márcio Barra, Cláudio David, João Costa, Joaquim J. Ferreira, Fausto J. Pinto" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Daniel" "apellidos" => "Caldeira" ] 1 => array:2 [ "nombre" => "Márcio" "apellidos" => "Barra" ] 2 => array:2 [ "nombre" => "Cláudio" "apellidos" => "David" ] 3 => array:2 [ "nombre" => "João" "apellidos" => "Costa" ] 4 => array:2 [ "nombre" => "Joaquim J." "apellidos" => "Ferreira" ] 5 => array:2 [ "nombre" => "Fausto J." "apellidos" => "Pinto" ] ] ] ] ] "idiomaDefecto" => "pt" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2174204914001706" "doi" => "10.1016/j.repce.2014.02.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204914001706?idApp=UINPBA00004E" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255114001474?idApp=UINPBA00004E" "url" => "/08702551/0000003300000009/v1_201410010215/S0870255114001474/v1_201410010215/pt/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S217420491400213X" "issn" => "21742049" "doi" => "10.1016/j.repce.2014.09.002" "estado" => "S300" "fechaPublicacion" => "2014-09-01" "aid" => "508" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Rev Port Cardiol. 2014;33:561.e1-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3237 "formatos" => array:3 [ "EPUB" => 180 "HTML" => 2534 "PDF" => 523 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>" "titulo" => "An unusual presentation of peripartum cardiomyopathy: Recurrent transient ischemic attacks" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "pt" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "561.e1" "paginaFinal" => "561.e3" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Uma apresentação não habitual de miocardiopatia periparto: acidentes isquémicos transitórios recorrentes" ] ] "contieneResumen" => array:2 [ "en" => true "pt" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1030 "Ancho" => 995 "Tamanyo" => 91820 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Normal cranial computed tomography scan.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Regayip Zehir, Can Yucel Karabay, Gonenc Kocabay, Arzu Kalayci, Taylan Akgun, Cevat Kirma" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Regayip" "apellidos" => "Zehir" ] 1 => array:2 [ "nombre" => "Can Yucel" "apellidos" => "Karabay" ] 2 => array:2 [ "nombre" => "Gonenc" "apellidos" => "Kocabay" ] 3 => array:2 [ "nombre" => "Arzu" "apellidos" => "Kalayci" ] 4 => array:2 [ "nombre" => "Taylan" "apellidos" => "Akgun" ] 5 => array:2 [ "nombre" => "Cevat" "apellidos" => "Kirma" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0870255114001905" "doi" => "10.1016/j.repc.2014.02.025" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255114001905?idApp=UINPBA00004E" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217420491400213X?idApp=UINPBA00004E" "url" => "/21742049/0000003300000009/v1_201410030041/S217420491400213X/v1_201410030041/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S2174204914002128" "issn" => "21742049" "doi" => "10.1016/j.repce.2014.03.009" "estado" => "S300" "fechaPublicacion" => "2014-09-01" "aid" => "501" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Port Cardiol. 2014;33:545-53" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3684 "formatos" => array:3 [ "EPUB" => 206 "HTML" => 2845 "PDF" => 633 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Prehospital activation of cardiac catheterization teams in ST-segment elevation myocardial infarction" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "pt" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "545" "paginaFinal" => "553" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Ativação pré-hospitalar da equipa de angioplastia primária no enfarte agudo miocárdio com elevação do segmento ST" ] ] "contieneResumen" => array:2 [ "en" => true "pt" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1257 "Ancho" => 2674 "Tamanyo" => 121102 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">System delay and cath lab activation delay before and after initiation of the new primary PCI protocol. CLAD: cath lab activation delay; PCI: percutaneous coronary intervention.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Eduardo Franco, Alonso Mateos, Carlos Acebal, Antonio Fernández-Ortiz, Vicente Sánchez-Brunete, Juan Carlos García-Rubira, María José Fernández-Campos, Carlos Macaya, Borja Ibáñez" "autores" => array:9 [ 0 => array:2 [ "nombre" => "Eduardo" "apellidos" => "Franco" ] 1 => array:2 [ "nombre" => "Alonso" "apellidos" => "Mateos" ] 2 => array:2 [ "nombre" => "Carlos" "apellidos" => "Acebal" ] 3 => array:2 [ "nombre" => "Antonio" "apellidos" => "Fernández-Ortiz" ] 4 => array:2 [ "nombre" => "Vicente" "apellidos" => "Sánchez-Brunete" ] 5 => array:2 [ "nombre" => "Juan Carlos" "apellidos" => "García-Rubira" ] 6 => array:2 [ "nombre" => "María José" "apellidos" => "Fernández-Campos" ] 7 => array:2 [ "nombre" => "Carlos" "apellidos" => "Macaya" ] 8 => array:2 [ "nombre" => "Borja" "apellidos" => "Ibáñez" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0870255114001838" "doi" => "10.1016/j.repc.2014.03.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255114001838?idApp=UINPBA00004E" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204914002128?idApp=UINPBA00004E" "url" => "/21742049/0000003300000009/v1_201410030041/S2174204914002128/v1_201410030041/en/main.assets" ] "en" => array:21 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "The prevalence of oral anticoagulation in patients with atrial fibrillation in Portugal: Systematic review and meta-analysis of observational studies" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "555" "paginaFinal" => "560" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Daniel Caldeira, Márcio Barra, Cláudio David, João Costa, Joaquim J. Ferreira, Fausto J. Pinto" "autores" => array:6 [ 0 => array:4 [ "nombre" => "Daniel" "apellidos" => "Caldeira" "email" => array:1 [ 0 => "dgcaldeira@hotmail.com" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Márcio" "apellidos" => "Barra" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Cláudio" "apellidos" => "David" "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "João" "apellidos" => "Costa" "referencia" => array:4 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] 3 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 4 => array:3 [ "nombre" => "Joaquim J." "apellidos" => "Ferreira" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 5 => array:3 [ "nombre" => "Fausto J." "apellidos" => "Pinto" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] ] "afiliaciones" => array:5 [ 0 => array:3 [ "entidad" => "Unidade de Farmacologia Clínica, Instituto de Medicina Molecular, Lisboa, Portugal" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Departamento de Cardiologia, CCUL, CAML, Universidade de Lisboa, Lisboa, Portugal" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Centro de Estudos de Medicina Baseada na Evidência (CEMBE), Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Centro Português da Rede Cochrane Iberoamericana, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal" "etiqueta" => "e" "identificador" => "aff0025" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Prevalência da anticoagulação oral em doentes com fibrilhação auricular em Portugal: revisão sistemática e meta-análise de estudos observacionais" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1639 "Ancho" => 2257 "Tamanyo" => 244059 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Prevalence of oral anticoagulation in patients with atrial fibrillation. CI: confidence interval; OAC: oral anticoagulation.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Atrial fibrillation (AF) is the most common arrhythmia in clinical practice, with an estimated prevalence of 2.5% in the Portuguese population aged 40 and over according to the FAMA study. The prevalence increases with age, reaching 6.6% in the group aged 70 and over and 10.5% in those aged 80 and over.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">In the FAMA study, a third of patients with AF were not aware that they had the condition. As AF can remain silent until complications occur,<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,3</span></a> clinical screening is indicated for individuals aged 65 or over.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> The main complications of AF are thromboembolic events, particularly stroke. For prevention of such events oral anticoagulation therapy (OAC) is recommended in patients with thromboembolic risk factors.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">The aim of this review was to estimate the prevalence of OAC therapy in patients with AF in Portugal by means of a systematic review and meta-analysis of epidemiologic studies.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Selection criteria</span><p id="par0020" class="elsevierStylePara elsevierViewall">Observational studies performed in mainland Portugal and/or the islands of Madeira and the Azores that enrolled patients with AF or atrial flutter (whether paroxysmal, persistent or permanent) and reported the proportion of anticoagulated patients were included. Studies on specific populations or on specific interventions such as AF ablation were excluded since inclusion of patients who are not representative of the general AF population would introduce bias.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Databases and searches</span><p id="par0025" class="elsevierStylePara elsevierViewall">MEDLINE, the Index of Portuguese Medical Journals and SIBUL (the Bibliographic Catalog of the Integrated Library System of the University of Lisbon) were searched. The search included review of the references lists of the studies and literature reviews found, but did not include abstracts of posters or oral communications at congresses.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Selection of studies and data extraction</span><p id="par0030" class="elsevierStylePara elsevierViewall">Potentially eligible studies were selected independently by two of the authors using the above inclusion and exclusion criteria and entered in a data extraction form showing the demographic characteristics of the study, the thromboembolic risk factors of the population and the proportion of anticoagulated patients.</p><p id="par0035" class="elsevierStylePara elsevierViewall">The selected studies were assessed qualitatively using criteria related to sampling, measurement and analysis.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> No study was excluded on the basis of possible bias.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Any disagreement between the investigators was resolved by consensus.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Data synthesis</span><p id="par0045" class="elsevierStylePara elsevierViewall">The Stata<span class="elsevierStyleSup">®</span> Statistical Software Package, version 11.0 (StataCorp LP, College Station, TX), was used to synthesise the results through meta-analysis and to determine the pooled estimated prevalence of anticoagulated AF patients. In studies that stratified the population's thromboembolic risk, the denominator of prevalence was the proportion of patients indicated for OAC. The results of the individual and pooled studies were expressed in percentages (prevalence) and 95% confidence intervals (CI). Inverse-variance weighting was used to aggregate the results of each study. As considerable heterogeneity between studies was expected, the random-effects model of DerSimonian and Laird<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> was used by default.</p><p id="par0050" class="elsevierStylePara elsevierViewall">Statistical heterogeneity was assessed using the I<span class="elsevierStyleSup">2</span> test, which calculates the percentage of total variation across studies that is due to heterogeneity rather than chance.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> An I<span class="elsevierStyleSup">2</span> of ≥50% indicates significant heterogeneity.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">In a separate analysis, estimates of prevalence were calculated as a function of the environment of the study (community or hospital).</p></span></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Results</span><p id="par0060" class="elsevierStylePara elsevierViewall">Seven studies were included for analysis.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,9–14</span></a> Supplementary Data Figure 1 shows the flowchart for study selection. Three studies were cross-sectional<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,9,13</span></a> and four were longitudinal (three retrospective cohort studies<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">10–12</span></a> and one prospective cohort study<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a>). Three were conducted in the general community<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,9,13</span></a> and four in a hospital environment.<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">10–12,14</span></a> These studies enrolled a total of 891 AF patients eligible for OAC. Sample size ranged between 21 and 261 individuals, most of them elderly (mean age varying between 77 and 85.5 years) and thus generally at high thromboembolic risk. Three studies included patients with significant valve disease or mechanical valves: in Jorge et al., 29% of the population had at least moderate valve disease or mechanical valves,<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> in Ascenção et al., 20% had mitral stenosis,<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> and in Dores et al., 6% of the population had valvular AF.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> Thromboembolic risk stratification was performed using the CHADS<span class="elsevierStyleInf">2</span> and CHA<span class="elsevierStyleInf">2</span>DS<span class="elsevierStyleInf">2</span>-VASc scores and the risk categories proposed in the 2006 American College of Cardiology/American Heart Association/European Society of Cardiology (ACC/AHA/ESC) guidelines<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">32</span></a> (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Two studies did not report using any risk stratification tools.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,10</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0065" class="elsevierStylePara elsevierViewall">The main characteristics of the studies included are shown in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>. The quality of the methodology in all seven studies was reasonable. The main source of possible bias was the lack of representativeness of the sample – some studies were performed exclusively in a hospital environment or analyzed patient subgroups. A qualitative analysis of the risk of bias is presented in Supplementary Data Figure 2. The meta-analysis of the results reveals that the prevalence of OAC therapy in Portuguese patients with AF is 40% (95% CI: 32–48%), higher in community-based (45%; 95% CI: 37–52%) than in hospital-based studies (36%; 95% CI: 24–48%), although this difference was without statistical significance (p=0.20). These results are presented in <a class="elsevierStyleCrossRef" href="#fig0005">Figure 1</a>.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0070" class="elsevierStylePara elsevierViewall">To assess the effect of including studies that used different risk stratification tools, we analyzed the results for different subgroups. The differences between the estimates obtained by different methods were not significant (p=0.31); the prevalence of anticoagulated patients was higher (44% [37–51%] vs. 30% [15–45%]) in studies that reported using risk stratification tools than in those that did not, but this was also not statistically significant (p=0.10).</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Discussion</span><p id="par0075" class="elsevierStylePara elsevierViewall">AF is an important public health issue, particularly in Portugal, since it is a risk factor for stroke, a significant cause of morbidity and mortality in this country.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> The risk of stroke is five times higher in patients with AF, increasing with age.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> Over 15% of strokes are due to AF and they are generally more severe than those not associated with AF.<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">17,18</span></a> Stroke attributable to AF is associated with a 30-day mortality of 25% and one-year mortality of 50%.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a> These patients have longer hospital stays and greater use of health resources.<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">19,20</span></a></p><p id="par0080" class="elsevierStylePara elsevierViewall">There is solid evidence that OAC reduces the risk of thromboembolic events. Use of vitamin K antagonists is associated with a significant reduction of 64% in relative risk for stroke,<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">21</span></a> and the new oral anticoagulants (direct thrombin and Xa inhibitors) have been shown to be at least as effective as vitamin K antagonists.</p><p id="par0085" class="elsevierStylePara elsevierViewall">The low prevalence of anticoagulated patients found in this review underlines the need to promote change in prescribing habits. The prevalence found in this study (40%) is close to that in the Italian ISAF study (46%).<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a> However, another study in Italy, based on cardiology units, showed a considerably higher prevalence of anticoagulation in AF patients with indication for OAC,<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a> and other recent studies paint a more optimistic picture. The international prospective GARFIELD registry reported a prevalence of 62% of OAC in patients with AF and CHADS<span class="elsevierStyleInf">2</span> score ≥2<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a>; the German ATRIUM registry, based on primary care data, found a prevalence of 75% in patients with AF and high thromboembolic risk<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">25</span></a>; and the PREFER in AF registry, using data from seven European countries, showed a prevalence of 85%.<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">26</span></a></p><p id="par0090" class="elsevierStylePara elsevierViewall">Both in clinical trials and in the real world, various reasons have been put forward for the failure of physicians to prescribe OAC for AF patients.<a class="elsevierStyleCrossRefs" href="#bib0120"><span class="elsevierStyleSup">24,27</span></a></p><p id="par0095" class="elsevierStylePara elsevierViewall">In a hospital-based study, Dores et al. found that 19% of patients with AF were considered to be contraindicated for OAC, the most frequent reasons being previous bleeding dyscrasia, alcoholism, renal disease and inability to control INR.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a></p><p id="par0100" class="elsevierStylePara elsevierViewall">Pereira-Da-Silva et al. assessed predictors of non-prescription of OAC in 103 eligible patients with AF and the reasons given by physicians.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> On multivariate analysis, bedridden status or dementia and large number of bleeding risk factors predicted non-prescription. In the 68 patients who were not prescribed OAC, the most frequent reasons were high bleeding risk (56%), perceived lack of benefit (22%), inability to follow the therapeutic regimen (10%) and difficulty in monitoring INR (7%).<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> The reasons given for not prescribing new-generation anticoagulants were their high cost (some not being subsidized by the State), lack of expected benefit, and bleeding risk.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a></p><p id="par0105" class="elsevierStylePara elsevierViewall">Despite their cost, the new anticoagulants, as well as being cost-effective,<a class="elsevierStyleCrossRefs" href="#bib0140"><span class="elsevierStyleSup">28,29</span></a> can overcome some of the barriers to prescription, particularly because they do not require regular INR monitoring and have fewer drug-drug and drug-food interactions.</p><p id="par0110" class="elsevierStylePara elsevierViewall">The current European Society of Cardiology guidelines recommend thromboembolic risk stratification using the CHA<span class="elsevierStyleInf">2</span>DS<span class="elsevierStyleInf">2</span>-VASc score, a score of 0 indicating that the patient would not benefit from OAC.<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4,30</span></a> Some studies in this review used the previously recommended risk stratification tool, CHADS<span class="elsevierStyleInf">2</span>,<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">31</span></a> or the algorithm proposed in the 2006 ACC/AHA/ESC guidelines.<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">32</span></a> Since the latter two exclude or underestimate risk in a proportion of patients who would benefit from OAC, the prevalence of anticoagulation in patients indicated for the therapy could be even lower when based on the CHA<span class="elsevierStyleInf">2</span>DS<span class="elsevierStyleInf">2</span>-VASc score.</p><p id="par0115" class="elsevierStylePara elsevierViewall">Furthermore, two studies included a considerable number of patients with significant valve disease or prosthetic valves.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9,12</span></a> These patients are more likely to be anticoagulated than those with non-valvular AF; even so, the prevalence of OAC was low in both studies.</p><p id="par0120" class="elsevierStylePara elsevierViewall">The considerable heterogeneity found is not uncommon in prevalence studies, due to multiple factors related to patients, institutions and prescribers.</p><p id="par0125" class="elsevierStylePara elsevierViewall">The heterogeneity observed between studies in the community compared to those in a hospital environment may be due to various factors, the most obvious of which is the inclusion of Reis et al.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> in the meta-analysis. This is the oldest of the hospital-based studies, published in 2006 but analyzing OAC in patients admitted in 2004; in this year there were 122 patients hospitalized for AF, of whom 108 were indicated for long-term OAC, but only 22.2% of these were anticoagulated at discharge.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a></p><p id="par0130" class="elsevierStylePara elsevierViewall">There are several possible reasons for the low rate of OAC in hospital-based studies, particularly Reis et al., including older age and the presence of comorbidities that would tend to heighten perception of greater bleeding risk. Both these reasons have been put forward as a restraint on physicians prescribing OAC for fear of severe bleeding, or the belief that the thromboembolic risk is lower than the bleeding risk.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">33</span></a> Moreover, some of the studies included in our review predated the publication of the Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) study in 2007, which showed that warfarin with a target INR of 2.0–3.0 was superior to aspirin in preventing cardiovascular events in patients aged ≥75 years, with no significant differences in bleeding risk.<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">34</span></a></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Limitations</span><p id="par0135" class="elsevierStylePara elsevierViewall">The conclusions of this review should be assessed bearing in mind the inherent limitations of the methodology used (a meta-analysis of pooled study results rather than data on individual patients). The inclusion of different population samples, ages, environments (community vs. hospital) and thromboembolic risk stratification tools (CHADS<span class="elsevierStyleInf">2</span>, CHA<span class="elsevierStyleInf">2</span>DS<span class="elsevierStyleInf">2</span>-VASc and the 2006 ACC/AHA/ESC Guidelines), all of which lead to clinical heterogeneity, should be taken into consideration as well as the expected statistical heterogeneity.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Conclusions</span><p id="par0140" class="elsevierStylePara elsevierViewall">The prevalence of OAC in Portuguese patients with AF is around 40%. Despite the evidence and the recommendations concerning the reduction of thromboembolic risk in AF patients with this therapy, a significant proportion of the population at risk is not anticoagulated. The level of OAC prescription in these patients is an indication of the quality of health care, and there is an obvious need for change.</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Conflicts of interest</span><p id="par0145" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:12 [ 0 => array:2 [ "identificador" => "xres373993" "titulo" => array:5 [ 0 => "Abstract" 1 => "Introduction and Objectives" 2 => "Methods" 3 => "Results" 4 => "Conclusions" ] ] 1 => array:2 [ "identificador" => "xpalclavsec353042" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "xres373994" "titulo" => array:5 [ 0 => "Resumo" 1 => "Introdução e objetivo" 2 => "Métodos" 3 => "Resultados" 4 => "Conclusões" ] ] 3 => array:2 [ "identificador" => "xpalclavsec353041" "titulo" => "Palavras-chave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Methods" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Selection criteria" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Databases and searches" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Selection of studies and data extraction" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Data synthesis" ] ] ] 6 => array:2 [ "identificador" => "sec0035" "titulo" => "Results" ] 7 => array:2 [ "identificador" => "sec0040" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0045" "titulo" => "Limitations" ] 9 => array:2 [ "identificador" => "sec0050" "titulo" => "Conclusions" ] 10 => array:2 [ "identificador" => "sec0055" "titulo" => "Conflicts of interest" ] 11 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2014-01-19" "fechaAceptado" => "2014-02-24" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec353042" "palabras" => array:6 [ 0 => "Atrial fibrillation" 1 => "Anticoagulation" 2 => "Prevalence" 3 => "Coumarins" 4 => "Warfarin" 5 => "Vitamin K antagonists" ] ] ] "pt" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palavras-chave" "identificador" => "xpalclavsec353041" "palabras" => array:6 [ 0 => "Fibrilhação auricular" 1 => "Anticoagulação" 2 => "Prevalência" 3 => "Coumarinicos" 4 => "Varfarina" 5 => "Antagonistas da vitamina K" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span class="elsevierStyleSectionTitle" id="sect0010">Introduction and Objectives</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Oral anticoagulation (OAC) is an effective treatment in the prevention of thromboembolic events in patients with atrial fibrillation (AF). The aim of this review was to estimate the prevalence of OAC therapy in patients with AF in Portugal.</p> <span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">MEDLINE, the Index of Portuguese Medical Journals and SIBUL (the Bibliographic Catalog of the Integrated Library System of the University of Lisbon) were searched for Portuguese observational studies reporting the proportion of anticoagulated patients with AF. The pooled estimated prevalence of anticoagulated patients and respective 95% confidence interval (CI) were determined by means of a meta-analysis.</p> <span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Seven studies were included for analysis, of which four were conducted in a hospital environment and three in the general community. These studies enrolled a total of 891 patients with AF. The pooled estimated prevalence of anticoagulated patients was 40% (95% CI: 32–48%).</p> <span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">The prevalence of OAC in Portuguese AF patients is low. There is a need to promote change in OAC prescribing habits for AF patients in Portugal, in accordance with international guidelines.</p>" ] "pt" => array:2 [ "titulo" => "Resumo" "resumen" => "<span class="elsevierStyleSectionTitle" id="sect0035">Introdução e objetivo</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A anticoagulação oral é uma terapêutica eficaz na prevenção de eventos tromboembólicos, em doentes com fibrilhação auricular (FA). A presente revisão pretendeu estimar a prevalência da terapêutica anticoagulante oral em doentes com FA em Portugal.</p> <span class="elsevierStyleSectionTitle" id="sect0040">Métodos</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Foi realizada uma pesquisa nas bases de dados MEDLINE, Índex de Revistas Médicas Portuguesas e Catálogo Bibliográfico do Sistema Integrado de Bibliotecas da antiga Universidade Clássica de Lisboa (SIBUL). Estudos observacionais nacionais que reportavam a proporção de doentes anticoagulados com fibrilhação auricular foram incluídos. A estimativa combinada de prevalência de doentes com FA anticoagulados e o respetivo intervalo de confiança 95% (IC95%) foi determinada com recurso a meta-análise.</p> <span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Dos sete estudos incluídos, três estudos foram realizados em ambiente hospitalar e quatro foram realizados na comunidade em geral. Do total de 891 doentes com FA, a estimativa de prevalência de doentes anticoagulados foi de 40% (IC95% 32-48%).</p> <span class="elsevierStyleSectionTitle" id="sect0050">Conclusões</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">A prevalência de doentes com FA anticoagulados na população estudada é baixa. É necessário promover a mudança dos hábitos de prescrição de anticoagulantes em doentes com FA em Portugal, em concordância com as recomendações internacionais.</p>" ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Caldeira D, Barra M, David C, et al. Prevalência da anticoagulação oral em doentes com fibrilhação auricular em Portugal: revisão sistemática e meta-análise de estudos observacionais. Rev Port Cardiol. 2014;33:555–560.</p>" ] ] "apendice" => array:1 [ 0 => array:1 [ "seccion" => array:1 [ 0 => array:4 [ "apendice" => "<p id="par0160" class="elsevierStylePara elsevierViewall"><elsevierMultimedia ident="upi0005"></elsevierMultimedia><elsevierMultimedia ident="upi0010"></elsevierMultimedia></p>" "etiqueta" => "Appendix A" "titulo" => "Supplementary data" "identificador" => "sec0070" ] ] ] ] "multimedia" => array:4 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1639 "Ancho" => 2257 "Tamanyo" => 244059 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Prevalence of oral anticoagulation in patients with atrial fibrillation. CI: confidence interval; OAC: oral anticoagulation.</p>" ] ] 1 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">ACC/AHA/ESC: American College of Cardiology/American Heart Association/European Society of Cardiology; AF: atrial fibrillation; CHLC: Centro Hospitalar Lisboa Central; HFF: Hospital Prof. Dr. Fenando Fonseca; HSFX: Hospital São Francisco Xavier; HUC: Hospitais da Universidade de Coimbra; OAC: oral anticoagulation; USF: Family Health Unit.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Study \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Study designEnvironment \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Study period \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Patients eligible for OAC (n) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Mean/median age (years) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Indication for OAC \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Ascenção et al.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cross-sectionalCommunity (general practitioner sentinel network) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">June 2003–November 2003 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">243 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">84% >65 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">CHADS<span class="elsevierStyleInf">2</span> ≥2, mitral stenosis or intracavitary thrombus \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Reis et al.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RetrospectiveHospital (HFF) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">January 1996–December 2004 (data from 2004) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">108 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">78.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Bonhorst et al.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cross-sectionalCommunity \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">119 (previous diagnosis of AF)/69% total AF \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">77 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Dores et al.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RetrospectiveHospital (HSFX) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">October 2006–October 2007 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">126 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">77 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Moderate to high risk according to 2006 ACC/AHA/ESC guidelines \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Jorge et al.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RetrospectiveHospital (HUC) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">December 2005–June 2007 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">161 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">80.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">CHADS<span class="elsevierStyleInf">2</span> ≥2 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Sá et al.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cross-sectionalCommunity (USFSaúde em Família, Maia) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2011 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">31 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">85.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">CHA<span class="elsevierStyleInf">2</span>DS<span class="elsevierStyleInf">2</span>-VASc ≥2 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Pereira-Da-Silva et al.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RetrospectiveHospital (CHLC) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">April 2011–October 2011 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">103 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">79.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">CHA<span class="elsevierStyleInf">2</span>DS<span class="elsevierStyleInf">2</span>-VASc ≥2 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab566013.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Main characteristics of the selected studies.</p>" ] ] 2 => array:5 [ "identificador" => "upi0005" "tipo" => "MULTIMEDIAECOMPONENTE" "mostrarFloat" => false "mostrarDisplay" => true "Ecomponente" => array:2 [ "fichero" => "mmc1.doc" "ficheroTamanyo" => 367616 ] ] 3 => array:5 [ "identificador" => "upi0010" "tipo" => "MULTIMEDIAECOMPONENTE" "mostrarFloat" => false "mostrarDisplay" => true "Ecomponente" => array:2 [ "fichero" => "mmc2.doc" "ficheroTamanyo" => 114176 ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:34 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the FAMA study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D. Bonhorst" 1 => "M. Mendes" 2 => "P. Adragão" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Port Cardiol" "fecha" => "2010" "volumen" => "29" "paginaInicial" => "331" "paginaFinal" => "350" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20635561" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "G.Y. Lip" 1 => "D.J. Golding" 2 => "M. Nazir" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br J Gen Pract" "fecha" => "1997" "volumen" => "47" "paginaInicial" => "285" "paginaFinal" => "289" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9219403" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increasing prevalence of atrial fibrillation and flutter in the United States" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "G.V. Naccarelli" 1 => "H. Varker" 2 => "J. Lin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2009.07.022" "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2009" "volumen" => "104" "paginaInicial" => "1534" "paginaFinal" => "1539" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19932788" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery" "etal" => true "autores" => array:3 [ 0 => "A.J. Camm" 1 => "P. Kirchhof" 2 => "G.Y. Lip" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehq278" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2010" "volumen" => "31" "paginaInicial" => "2369" "paginaFinal" => "2429" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20802247" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Guidelines for evaluating prevalence studies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M.H. Boyle" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Evid Based Ment Health" "fecha" => "1998" "volumen" => "1" "paginaInicial" => "37" "paginaFinal" => "39" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Meta-analysis in clinical trials" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R. DerSimonian" 1 => "N. Laird" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Control Clin Trials" "fecha" => "1986" "volumen" => "7" "paginaInicial" => "177" "paginaFinal" => "188" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3802833" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.J. Deeks" 1 => "D.G. Altman" 2 => "M.J. Bradburn" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:5 [ "titulo" => "Systematic reviews in health care: meta-analysis in context" "paginaInicial" => "313" "paginaFinal" => "335" "edicion" => "2nd ed." "serieFecha" => "2001" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available at <a id="intr0015" class="elsevierStyleInterRef" href="http://www.cochrane-handbook.org/">www.cochrane-handbook.org</a>." ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fibrilhação auricular e prevenção do tromboembolismo. Estudo numa população de utentes de Centros de Saúde" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "P. Ascenção" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Port Clin Geral" "fecha" => "2006" "volumen" => "22" "paginaInicial" => "13" "paginaFinal" => "24" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fibrilhação auricular: das guidelines à realidade" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P. Reis" 1 => "T. Patrícia" 2 => "L. Dutschmann" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Interna" "fecha" => "2006" "volumen" => "13" "paginaInicial" => "155" "paginaFinal" => "161" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atrial fibrillation and thromboembolic risk: what is the extent of adherence to guidelines in clinical practice?" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "H. Dores" 1 => "R. Cardiga" 2 => "R. Ferreira" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Port Cardiol" "fecha" => "2011" "volumen" => "30" "paginaInicial" => "171" "paginaFinal" => "180" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21553610" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anticoagulation in elderly patients with atrial fibrillation: from the guidelines to the daily medical practice" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "E. Jorge" 1 => "F.S. Pereira" 2 => "R. Baptista" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acta Med Port" "fecha" => "2011" "volumen" => "24" "paginaInicial" => "293" "paginaFinal" => "300" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22849915" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anticoagulação oral nos muito idosos e seus determinantes clínicos" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M.C. Sá" 1 => "M.J. Balsa" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Port Med Geral Fam" "fecha" => "2012" "volumen" => "28" "paginaInicial" => "168" "paginaFinal" => "176" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Restraints to anticoagulation prescription in atrial fibrillation and attitude towards the new oral anticoagulants" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "T. Pereira-Da-Silva" 1 => "T. Souto Moura" 2 => "L. Azevedo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acta Med Port" "fecha" => "2013" "volumen" => "26" "paginaInicial" => "127" "paginaFinal" => "132" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23809744" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Portugal – Doença cerebro-cardiovasculares em números – 2013; Direcção Geral da Saúde. <a id="intr0020" class="elsevierStyleInterRef" href="http://www.spc.pt/DL/Home/fm/i019350.pdf">http://www.spc.pt/DL/Home/fm/i019350.pdf</a> [accessed November 2013]." ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atrial fibrillation as an independent risk factor for stroke: the Framingham Study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P.A. Wolf" 1 => "R.D. Abbott" 2 => "W.B. Kannel" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "1991" "volumen" => "22" "paginaInicial" => "983" "paginaFinal" => "988" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1866765" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Stroke severity in atrial fibrillation. The Framingham Study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "H.J. Lin" 1 => "P.A. Wolf" 2 => "M. Kelly-Hayes" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "1996" "volumen" => "27" "paginaInicial" => "1760" "paginaFinal" => "1764" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8841325" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atrial fibrillation is associated with severe acute ischemic stroke" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D.A. Dulli" 1 => "H. Stanko" 2 => "R.L. Levine" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "68743" "Revista" => array:6 [ "tituloSerie" => "Neuroepidemiology" "fecha" => "2003" "volumen" => "22" "paginaInicial" => "118" "paginaFinal" => "123" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12629277" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of atrial fibrillation on mortality, stroke, and medical costs" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "P.A. Wolf" 1 => "J.B. Mitchell" 2 => "C.S. Baker" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Intern Med" "fecha" => "1998" "volumen" => "158" "paginaInicial" => "229" "paginaFinal" => "234" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9472202" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "O. Ghatnekar" 1 => "E.L. Glader" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1524-4733.2008.00359.x" "Revista" => array:6 [ "tituloSerie" => "Value Health" "fecha" => "2008" "volumen" => "11" "paginaInicial" => "862" "paginaFinal" => "868" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18489491" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R.G. Hart" 1 => "L.A. Pearce" 2 => "M.I. Aguilar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "2007" "volumen" => "146" "paginaInicial" => "857" "paginaFinal" => "867" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17577005" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frequency, patient characteristics, treatment strategies, and resource usage of atrial fibrillation (from the Italian Survey of Atrial Fibrillation Management [ISAF] study)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "M. Zoni-Berisso" 1 => "A. Filippi" 2 => "M. Landolina" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2012.11.026" "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2013" "volumen" => "111" "paginaInicial" => "705" "paginaFinal" => "711" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23273528" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anticoagulation in “real world” patients with atrial fibrillation in Italy: results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "M. Volterrani" 1 => "F. Iellamo" 2 => "G. Rosano" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ijcard.2013.07.169" "Revista" => array:6 [ "tituloSerie" => "Int J Cardiol" "fecha" => "2013" "volumen" => "168" "paginaInicial" => "4729" "paginaFinal" => "4733" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23948115" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A.K. Kakkar" 1 => "I. Mueller" 2 => "J.P. Bassand" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0063479" "Revista" => array:5 [ "tituloSerie" => "PLOS ONE" "fecha" => "2013" "volumen" => "8" "paginaInicial" => "e63479" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23704912" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "T. Meinertz" 1 => "W. Kirch" 2 => "L. Rosin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00392-011-0320-5" "Revista" => array:6 [ "tituloSerie" => "Clin Res Cardiol" "fecha" => "2011" "volumen" => "100" "paginaInicial" => "897" "paginaFinal" => "905" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21533828" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboembolic events—European Registry in Atrial Fibrillation (PREFER in AF)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "P. Kirchhof" 1 => "B. Ammentorp" 2 => "H. Darius" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Europace" "fecha" => "2013" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Apixaban in patients with atrial fibrillation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "S.J. Connolly" 1 => "J. Eikelboom" 2 => "C. Joyner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1007432" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2011" "volumen" => "364" "paginaInicial" => "806" "paginaFinal" => "817" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21309657" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "B.L. Limone" 1 => "W.L. Baker" 2 => "J. Kluger" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0062183" "Revista" => array:5 [ "tituloSerie" => "PLOS ONE" "fecha" => "2013" "volumen" => "8" "paginaInicial" => "e62183" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23626785" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cost-effectiveness of oral anticoagulants for treatment of atrial fibrillation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "W.J. Canestaro" 1 => "A.R. Patrick" 2 => "J. Avorn" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCOUTCOMES.113.000661" "Revista" => array:6 [ "tituloSerie" => "Circ Cardiovasc Qual Outcomes" "fecha" => "2013" "volumen" => "6" "paginaInicial" => "724" "paginaFinal" => "731" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24221832" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0150" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A.J. Camm" 1 => "G.Y. Lip" 2 => "R. De Caterina" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehs253" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2012" "volumen" => "33" "paginaInicial" => "2719" "paginaFinal" => "2747" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22922413" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0155" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "T.B. Larsen" 1 => "G.Y. Lip" 2 => "F. Skjøth" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCOUTCOMES.111.964023" "Revista" => array:6 [ "tituloSerie" => "Circ Cardiovasc Qual Outcomes" "fecha" => "2012" "volumen" => "5" "paginaInicial" => "335" "paginaFinal" => "342" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22534406" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0160" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "V. Fuster" 1 => "L.E. Rydén" 2 => "D.S. Cannom" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/europace/eul097" "Revista" => array:6 [ "tituloSerie" => "Europace" "fecha" => "2006" "volumen" => "8" "paginaInicial" => "651" "paginaFinal" => "745" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16987906" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0165" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP Project" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "H.J. Chang" 1 => "J.R. Bell" 2 => "D.B. Deroo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Intern Med" "fecha" => "1990" "volumen" => "150" "paginaInicial" => "83" "paginaFinal" => "86" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2297300" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0170" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study BAFTA): a randomised controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J. Mant" 1 => "F.D. Hobbs" 2 => "K. Fletcher" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(07)61233-1" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2007" "volumen" => "370" "paginaInicial" => "493" "paginaFinal" => "503" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17693178" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21742049/0000003300000009/v1_201410030041/S2174204914001706/v1_201410030041/en/main.assets" "Apartado" => array:4 [ "identificador" => "9924" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Review Article" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21742049/0000003300000009/v1_201410030041/S2174204914001706/v1_201410030041/en/main.pdf?idApp=UINPBA00004E&text.app=https://revportcardiol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204914001706?idApp=UINPBA00004E" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 2 | 6 |
2024 October | 21 | 12 | 33 |
2024 September | 45 | 27 | 72 |
2024 August | 34 | 28 | 62 |
2024 July | 39 | 30 | 69 |
2024 June | 39 | 20 | 59 |
2024 May | 41 | 25 | 66 |
2024 April | 36 | 15 | 51 |
2024 March | 41 | 19 | 60 |
2024 February | 23 | 21 | 44 |
2024 January | 21 | 21 | 42 |
2023 December | 26 | 27 | 53 |
2023 November | 30 | 26 | 56 |
2023 October | 45 | 16 | 61 |
2023 September | 28 | 19 | 47 |
2023 August | 28 | 18 | 46 |
2023 July | 27 | 12 | 39 |
2023 June | 21 | 18 | 39 |
2023 May | 31 | 21 | 52 |
2023 April | 15 | 3 | 18 |
2023 March | 25 | 17 | 42 |
2023 February | 24 | 25 | 49 |
2023 January | 23 | 13 | 36 |
2022 December | 24 | 26 | 50 |
2022 November | 49 | 29 | 78 |
2022 October | 26 | 17 | 43 |
2022 September | 32 | 28 | 60 |
2022 August | 38 | 35 | 73 |
2022 July | 23 | 38 | 61 |
2022 June | 24 | 21 | 45 |
2022 May | 21 | 32 | 53 |
2022 April | 28 | 31 | 59 |
2022 March | 25 | 31 | 56 |
2022 February | 29 | 32 | 61 |
2022 January | 26 | 15 | 41 |
2021 December | 19 | 29 | 48 |
2021 November | 26 | 36 | 62 |
2021 October | 33 | 39 | 72 |
2021 September | 17 | 28 | 45 |
2021 August | 26 | 34 | 60 |
2021 July | 29 | 16 | 45 |
2021 June | 20 | 26 | 46 |
2021 May | 44 | 34 | 78 |
2021 April | 43 | 28 | 71 |
2021 March | 35 | 15 | 50 |
2021 February | 57 | 17 | 74 |
2021 January | 30 | 14 | 44 |
2020 December | 17 | 6 | 23 |
2020 November | 36 | 16 | 52 |
2020 October | 19 | 10 | 29 |
2020 September | 49 | 7 | 56 |
2020 August | 20 | 6 | 26 |
2020 July | 55 | 6 | 61 |
2020 June | 44 | 4 | 48 |
2020 May | 34 | 4 | 38 |
2020 April | 40 | 7 | 47 |
2020 March | 49 | 6 | 55 |
2020 February | 104 | 25 | 129 |
2020 January | 59 | 4 | 63 |
2019 December | 39 | 5 | 44 |
2019 November | 46 | 5 | 51 |
2019 October | 54 | 5 | 59 |
2019 September | 66 | 9 | 75 |
2019 August | 47 | 7 | 54 |
2019 July | 46 | 7 | 53 |
2019 June | 38 | 17 | 55 |
2019 May | 49 | 9 | 58 |
2019 April | 36 | 12 | 48 |
2019 March | 121 | 9 | 130 |
2019 February | 94 | 8 | 102 |
2019 January | 39 | 5 | 44 |
2018 December | 68 | 9 | 77 |
2018 November | 118 | 10 | 128 |
2018 October | 407 | 15 | 422 |
2018 September | 146 | 17 | 163 |
2018 August | 115 | 11 | 126 |
2018 July | 41 | 4 | 45 |
2018 June | 46 | 10 | 56 |
2018 May | 43 | 13 | 56 |
2018 April | 38 | 15 | 53 |
2018 March | 48 | 7 | 55 |
2018 February | 17 | 3 | 20 |
2018 January | 33 | 12 | 45 |
2017 December | 55 | 12 | 67 |
2017 November | 50 | 14 | 64 |
2017 October | 34 | 13 | 47 |
2017 September | 44 | 13 | 57 |
2017 August | 46 | 10 | 56 |
2017 July | 36 | 12 | 48 |
2017 June | 52 | 8 | 60 |
2017 May | 51 | 9 | 60 |
2017 April | 43 | 9 | 52 |
2017 March | 45 | 38 | 83 |
2017 February | 41 | 10 | 51 |
2017 January | 53 | 7 | 60 |
2016 December | 55 | 19 | 74 |
2016 November | 58 | 10 | 68 |
2016 October | 38 | 9 | 47 |
2016 September | 35 | 8 | 43 |
2016 August | 14 | 0 | 14 |
2016 July | 21 | 9 | 30 |
2016 June | 16 | 11 | 27 |
2016 May | 16 | 5 | 21 |
2016 April | 41 | 2 | 43 |
2016 March | 61 | 24 | 85 |
2016 February | 78 | 34 | 112 |
2016 January | 54 | 24 | 78 |
2015 December | 68 | 24 | 92 |
2015 November | 53 | 21 | 74 |
2015 October | 73 | 12 | 85 |
2015 September | 56 | 13 | 69 |
2015 August | 47 | 14 | 61 |
2015 July | 42 | 12 | 54 |
2015 June | 50 | 6 | 56 |
2015 May | 34 | 13 | 47 |
2015 April | 36 | 21 | 57 |
2015 March | 54 | 11 | 65 |
2015 February | 49 | 13 | 62 |
2015 January | 61 | 25 | 86 |
2014 December | 79 | 36 | 115 |
2014 November | 70 | 21 | 91 |
2014 October | 140 | 70 | 210 |